Pyxis Oncology, Inc. ( PYXS) - Key Metrics
PYXS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.40 | -$0.28 | -$0.28 |
| 2026Q1 | $0 | -$0.37 | -$0.41 | -$0.41 |
| 2025Q4 | $0.18 | -$0.29 | -$0.17 | -$0.17 |
| 2025Q3 | $0 | -$0.35 | -$0.21 | -$0.21 |
| 2025Q2 | $0.05 | -$0.30 | -$0.28 | -$0.28 |
PYXS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.88 |
| 2026Q1 | 0% | -0.99 |
| 2025Q4 | 0% | -0.99 |
| 2025Q3 | 0% | -1.59 |
| 2025Q2 | 0% | -0.92 |
PYXS
Price: $3.21
52 week price:
Earnings Per Share: -1.35 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 10300
Market Capitalization: 246.5 million